In intrahepatic cholangiocarcinoma, FGFR2 REs significantly co-occurred with BAP1 alterations, whereas KRAS, TP53, IDH1, and ARID1A alterations were mutually exclusive. This evidence concerns the gene BAP1 and intrahepatic cholangiocarcinoma.